Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 6A29UE2ZGG

Pharmacology

Action Mechanism of Action Reference
INHIBITOR T-cell receptor inhibitor

Cross References

Resources Reference
ChEMBL CHEMBL2108474
FDA SRS 6A29UE2ZGG